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Introduction: Conventional risk factors targeted by prevention (e.g., low education,
smoking, and obesity) are associated with a 1.2- to 2-fold increased risk of dementia.
It is unclear whether having a physical disease is an equally important risk factor for
dementia.
Methods: In this exploratory multicohort study of 283,414 community-dwelling par-
ticipants, we examined 22 common hospital-treated physical diseases as risk factors
for dementia.
Results: During a median follow-up of 19 years, a total of 3416 participants devel-
oped dementia. Those who had erysipelas (hazard ratio = 1.82; 95% confidence inter-
val = 1.53 to 2.17), hypothyroidism (1.94; 1.59 to 2.38), myocardial infarction (1.41;
1.20 to 1.64), ischemic heart disease (1.32; 1.18 to 1.49), cerebral infarction (2.44;
2.14 to 2.77), duodenal ulcers (1.88; 1.42 to 2.49), gastritis and duodenitis (1.82; 1.46
to 2.27), or osteoporosis (2.38; 1.75 to 3.23) were at a significantly increased risk
of dementia. These associations were not explained by conventional risk factors or
reverse causation.
Discussion: In addition to conventional risk factors, several physical diseases may
increase the long-term risk of dementia.
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1 INTRODUCTION
Because no treatment to stop or delay the progression of demen-
tia is available, prevention remains the primary means to combat
the disease.1,2 The National Academies of Sciences, Engineering, and
Medicine recommend three targets for dementia prevention: cog-
nitive training, management of hypertension, and physical activity.3
The 2017 Lancet Commission,1 and more recently, the World Health
Organization4 have highlighted further potentially modifiable risk fac-
tors, including low education, obesity, hearing loss, smoking, depres-
sion, social isolation, and diabetes. The associations between these
risk factors and dementia are, however, relatively modest, with meta-
analyses reporting relative risk estimates of two or below.1,5–12
Many people with dementia are affected by multiple other physical
diseases13,14 thatmay also increase the risk of dementia, although they
are not currently acknowledged as targets for dementia prevention.
These include cardiovascular disease and some autoimmune, inflam-
matory, and infectious diseases.15–19 Genetic studies, supporting the
role of these diseases in the development of dementia, have found
shared genetic variants for lipid metabolism, the immune system, and
Alzheimer’s disease, a common form of dementia.20,21 To date, how-
ever, few studies have systematically compared the magnitude of the
dementia risk associated with conventional risk factors and physical
diseases.
To address this limitation, we examined the association between 22
potentially dementia-related physical diseases22 and incident all-cause
dementia before and after adjustment for conventional risk factors.
Using a data-driven approach, our aim was to generate new hypothe-
ses for research on the prevention and etiology of dementia. To mini-
mize ascertainment and reverse causation biases, we excluded the first
10 years of follow-up in the sensitivity analyses.10
2 METHODS
2.1 Study population
This analysis is based on four prospective cohort studies linked to
national health registries: the Finnish Public Sector study (FPS), the
Health and Social Support study (HeSSup), and the Still Working study
(STW) in Finland, and the Whitehall II study (WHII) in the UK. Of the
351,331 participants eligible for this study, we selected adults aged
18 years or older, who were successfully linked to hospitalization reg-
isters and free of known dementia at study entry: a total of 283,414
men and women (Figure A.1 andMethods A.1 in the Appendix). A local
ethics committee approved data collection and analysis for all the stud-
ies (Methods A.1 in the Appendix).
2.2 Diagnoses of hospital-treated diseases
We linked participants to the records of national health registers and
retrieved both primary and secondary diagnoses from inpatient hospi-
HIGHLIGHTS
∙ Multicohort studyof22physical diseases as long-termrisk
factors for dementia
∙ Eight vascular, inflammatory, and bone diseases were
linked to increased dementia risk
∙ The associations were as strong as those between stan-
dard risk factors and dementia
RESEARCH INCONTEXT
1. Systematic review: The National Academies of Sciences,
Engineering, andMedicine recommendcognitive training,
management of hypertension, and physical activity for
dementia prevention. Other major guidelines addition-
ally recommend targeting low education, obesity, hear-
ing loss, smoking, depression, social isolation, and dia-
betes. Although many physical diseases have been found
to increase the risk of dementia, current guidelines recog-
nize only three: hypertension, diabetes, and hearing loss.
2. Interpretation: This data-driven multicohort study of
283,414 individuals followed up for a median of 19 years
found eight physical diseases to be at least as strongly
related to increased dementia risk as the conventional
dementia risk factors. These diseases were erysipelas,
hypothyroidism, myocardial infarction, chronic ischemic
heart disease, cerebral infarction, duodenal ulcer, gastri-
tis and duodenitis, and osteoporosis.
3. Future directions: Future research on underlying mech-
anisms would help evaluate whether these disease–
dementia associations are causal.
tal discharge information using the International Classification of Dis-
eases, 10th Revision (ICD-10). The diagnosis codes from the 8th and
9th revisions (ICD-8 and ICD-9) were converted into the correspond-
ing ICD-10 codes (Table A.1 in the Appendix). To avoid false-positive
findings and publication bias, we systematically considered 32 phys-
ical diseases that were associated with an elevated 5-year incidence
of at least one type of dementia (or were on a disease trajectory later
leading to dementia) in a hypothesis-freeDanish total population study
with rigorous control for multiple testing.22 We excluded diseases in
ICD-10Chapters V (Mental and behavioral disorders) and VI (Diseases
of the nervous system) because their relation to dementia has already
been studied extensively.9,23,24 We found sufficient case numbers in
our data for 25 of these physical diseases (i.e., a minimum of three inci-
dent dementia cases that occurred more than 10 years after the diag-
nosis of the disease). Current prevention guidelines1,4 acknowledge
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three of these diseases (type 1 and 2 diabetes and hypertension) as
dementia risk factors, so we examined 22 other physical diseases as
potential risk factors for dementia (Figure 1).
2.3 Covariates
We included the following covariates:1 age, sex, low educa-
tion/socioeconomic status, hypertension, smoking, depression,
physical inactivity, diabetes, marital status (a proxy for social isolation),
obesity (available in all cohorts except STW), and apolipoprotein E
(APOE) genotype (available inWHII). The definitions of these variables
in each study are provided inMethods A.1 in the Appendix.
2.4 Ascertainment of incident dementia
We focused on all-cause dementia because electronic health records
may not be a reliable source of data to ascertain specific dementia sub-
types. We compiled dementia diagnoses from hospital inpatient and
outpatient records, medication reimbursement entitlements for the
treatment of dementia, and causes of death, as available in each study
between study baseline (1986 to 2005) and the end of follow-up (2012
to 2017) (Methods A.1 in the Appendix). For anti-dementia medica-
tion reimbursement entitlements, dementia diagnosis has to be made
or confirmed in a neurology or geriatrics unit in secondary or tertiary
health care or by a qualified neurologist or geriatrician (a prerequisite
for reimbursement by the Finnish Social Insurance Institution).
In FPS, HeSSup, and STW, a diagnosis of dementia comprised ICD-
10 codes F00-F03, F05.1, G30, G31.0, G31.1, and G31.8, whereas in
WHII, it comprised ICD-10 codes F00, F01, F03, G30, and G31. We
defined the date of incident dementia as the first occurrence of demen-
tia diagnosis, whether primary or secondary, in any of these informa-
tion sources.
2.5 Statistical analysis
We computed hazard ratios for the associations of hospital-treated
physical diseases (index diseases) with dementia in separate Cox
proportional hazards models. We used a one-stage approach for a
pooled analysis of individual-level data from four cohort studies and
took the within-study clustering of participants into account using
cohort-specific baseline hazards and cohort-specific adjustment terms
for covariates.25 This means that individual-level data from the four
cohorts were analyzed in a single Cox model that was stratified by
cohort. The model produced a single effect estimate for the index dis-
ease, but the effect estimates for adjusting variables (sex in all mod-
els and conventional dementia risk factors in further adjusted mod-
els) were allowed to vary from cohort to cohort. All Cox models were
adjusted for age using age as the time scale.
Follow-up for incident dementia started at study entry and contin-
ued until dementia diagnosis, death, or end of follow-up, whichever
came first. We modeled exposure to the index diseases using time-
dependent analysis whenever hospitalization from the index disease
occurred after study entry (incident index disease).26 If hospitalization
occurred before study entry (prevalent index disease), the participant
contributed to the follow-up as exposed from study entry.We also per-
formed sensitivity analyses restricted to those free of the index disease
at study entry and after excluding dementia cases that lacked infor-
mation on the type of dementia. We examined the proportional haz-
ards assumption using scaled Schoenfeld residuals (Methods A.2 and
Figure A.2 in the Appendix). We analyzed early and late-onset demen-
tia as separate outcomes by splitting follow-up at age 65 (those whose
dementia onset was before age 65 vs those whose dementia onset was
at or after age 65).
To reduce the risk of ascertainment bias and reverse causation,
we repeated the analysis after excluding incident dementia cases that
occurred during the first 10 years after initial hospitalization for the
index disease (these biases mainly affect cases of dementia diagnosed
early in the follow-up).10,27 Ascertainment bias arises when medi-
cal attention for one disease increases the probability of detecting
another. Reverse causation bias occurs if the long preclinical phase of
dementia increases the risk of the index disease.17,28 For those not
exposed to the index disease at study entry, we also excluded dementia
cases occurring within the first 10 years of follow-up (Figure A.3 in the
Appendix).
We examined whether the index diseases were associated with
dementia independently of each other by entering them into the same
Cox model. Two diseases reflected coronary heart disease: myocar-
dial infarction and chronic ischemic heart disease. To avoid over-
adjustment, these two diseases were not adjusted for each other.
We used the Fine-Gray competing-risks model to compute sub-
hazard ratios with death without dementia as the competing outcome
event. The Fine-Gray model was specified analogously with the Cox
models. Age was the timescale, and the effect estimate for sex (the
adjusting variable) was allowed to vary from cohort to cohort. We also
adjusted the models for cohort and used robust standard errors that
were clustered for cohort.
To compare the relative dementia risk related to physical dis-
eases versus conventional potentially modifiable dementia risk factors
(low education/socioeconomic status, hypertension, obesity, smoking,
depression, physical inactivity, marital status, and diabetes), we com-
puted the hazard ratios for these risk factors using the same mod-
eling as for the index diseases. Because blood pressure and weight
declines in preclinical dementia, we analyzed hypertension and obe-
sity at middle age, excluding those aged 65 or older at baseline.29,30
Analogouslywith themodels for physical diseases, individual-level data
from the cohorts were analyzed in a single Cox model that produced
a single effect estimate for the risk factor of interest and was strati-
fied by cohort. Agewas the timescale and themodelswere adjusted for
sex, which was allowed to have different effect estimates for different
cohorts.
To assess the effect of conventional dementia risk factors on the
associations between physical diseases and dementia, we adjusted the
Coxmodels for these factors, sex, and the statistically significant inter-
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Full dementia follow-up (main analysis)
First 10 years of dementia follow-up excluded (sensitivity analysis)
Participants with index disease Participants without index disease
DISEASE CHAPTER Hazard ratio Hazard ratio
Disease (ICD-10 code) (95% confidence interval) (95% confidence interval)
CERTAIN INFECTIOUS AND PARASITIC DISEASES
Other gastroenteritis and colitis of infectious and unspecified origin (A09)* 2.04 (1.69-2.46) 7801 114 275613 3302
1.24 (0.88-1.76) 5829 32 272379 3027
Erysipelas (A46)*† 1.82 (1.53-2.17) 4542 135 278872 3281
1.59 (1.19-2.12) 1843 47 276256 3006
ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES
Other hypothyroidism (E03)*† 1.94 (1.59-2.38) 2702 99 280712 3317
2.20 (1.48-3.26) 704 25 277585 3046
Thyrotoxicosis [hyperthyroidism] (E05) 1.17 (0.74-1.83) 1205 19 282209 3397
0.91 (0.47-1.74) 693 9 277720 3121
Disorders of lipoprotein metabolism and other lipidaemias (E78)* 1.58 (1.36-1.82) 5788 214 277626 3202
1.42 (1.00-2.01) 1113 33 276930 2934
DISEASES OF THE EAR AND MASTOID PROCESS
Disorders of vestibular function (H81) 1.14 (0.84-1.54) 1737 42 281677 3374
1.02 (0.63-1.64) 814 17 277568 3098
DISEASES OF THE CIRCULATORY SYSTEM
Angina pectoris (I20)* 1.23 (1.09-1.40) 5265 274 278149 3142
1.19 (1.00-1.41) 2515 138 275603 2874
Acute myocardial infarction (I21)*† 1.41 (1.20-1.64) 4072 173 279342 3243
1.56 (1.18-2.06) 1119 53 277083 2970
Chronic ischemic heart disease (I25)*† 1.32 (1.18-1.49) 6719 330 276695 3086
1.28 (1.06-1.56) 2239 111 275685 2820
Atrial fibrillation and flutter (I48)* 1.41 (1.26-1.58) 7578 346 275836 3070
1.20 (0.97-1.49) 2115 87 275877 2798
Cerebral infarction (I63)*† 2.44 (2.14-2.77) 4201 265 279213 3151
2.15 (1.61-2.87) 899 47 277281 2883
Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction (I65) 1.72 (1.15-2.57) 412 24 283002 3392
1.55 (0.69-3.45) 99 6 278369 3117
DISEASES OF THE RESPIRATORY SYSTEM
Other chronic obstructive pulmonary disease (J44)* 1.83 (1.48-2.25) 2291 91 281123 3325
1.31 (0.78-2.22) 422 15 277910 3054
DISEASES OF THE DIGESTIVE SYSTEM
Esophagitis (K20) 1.54 (0.98-2.42) 536 19 282878 3397
1.56 (0.84-2.90) 281 10 278188 3119
Duodenal ulcer (K26)*† 1.88 (1.42-2.49) 1054 49 282360 3367
1.92 (1.36-2.71) 659 33 277796 3091
Gastritis and duodenitis (K29)*† 1.82 (1.46-2.27) 2280 84 281134 3332
1.48 (1.06-2.07) 1262 35 277121 3061
Other functional intestinal disorders (K59)* 2.21 (1.73-2.82) 1817 68 281597 3348
0.88 (0.44-1.75) 760 8 277645 3076
Other diseases of anus and rectum (K62) 1.18 (0.90-1.55) 2100 54 281314 3362
1.30 (0.86-1.98) 1007 22 277328 3088
Alcoholic liver disease (K70)* 2.95 (1.96-4.46) 1201 23 282213 3393
0.92 (0.30-2.87) 244 3 278157 3118
DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE
Other dermatitis (L30)* 2.13 (1.46-3.11) 745 27 282669 3389
0.86 (0.36-2.06) 381 5 278068 3111
DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE
Osteoporosis without pathological fracture (M81)*† 2.38 (1.75-3.23) 617 44 282797 3372
4.01 (1.79-8.99) 99 6 278362 3097
DISEASES OF THE GENITOURINARY SYSTEM
Hyperplasia of prostate (N40)* 1.56 (1.32-1.84) 2719 170 84817 1150
0.98 (0.69-1.39) 749 33 83922 1059
Favor lower risk Favor higher risk
Abbreviations: ICD-10, International Classification of Diseases, 10th Revision.
The bars represent 95% confidence intervals.
Age is the time scale and hazard ratios are adjusted for sex (hyperplasia of prostate was analyzed in men only).
Within-study clustering of participants was taken into account using cohort-specific baseline hazards and cohort-specific adjustment terms for sex.
*Significant association in the main analysis after Bonferroni correction for 22 tests (P < .0023).
†Significant association after Bonferroni correction in the main analysis and significant association (P < .05) in the sensitivity analysis excluding first 10 years of dementia follow-up.
(Exposure group) (Reference group)
0.25 0.5 1 2 4 8 1 6
N (total) N (dementia cases) N (total) N (dementia cases)
F IGURE 1 Hazard ratios for incident dementia by exposure to 22 hospital-treated diseases in main analysis (full follow-up) and in sensitivity
analysis (the first 10 years of dementia follow-up excluded). ICD-10, International Classification of Diseases, 10th Revision. The bars represent
95% confidence intervals. Age is the time scale and hazard ratios are adjusted for sex (hyperplasia of prostate was analyzed inmen only).
Within-study clustering of participants has been taken into account using cohort-specific baseline hazards and cohort-specific adjustment terms
for sex. *Significant association in themain analysis after Bonferroni correction for 22 tests (P< .0023). †Significant association after Bonferroni
correction in themain analysis and significant association (P< .05) in the sensitivity analysis excluding first 10 years of dementia follow-up.
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actions between the adjusting variables (indicated by a likelihood-ratio
test with P< .05) in a subcohort with relevant data available (Table A.2
in the Appendix). One cohort (STW) was excluded from these analyses
because no data on body mass index were available. As the main anal-
ysis, individual-level data from the cohorts were analyzed in a single
Cox model that was stratified by cohort. The model produced a single
estimate for the disease of interest, but the effect estimates for adjust-
ing variables (sex and the conventional potentiallymodifiable dementia
risk factors) and the interactions between them were allowed to vary
from cohort to cohort. The significant interactions were between sex
and marital status, low education/socioeconomic status and physical
inactivity, hypertension and marital status, obesity and smoking, and
smoking and depression. We were only able to model the interaction
between obesity and smoking for FPS andWHII, because HeSSup had
no dementia cases among those whowere both obese and smokers.
To examine the clustering of the index diseases that were asso-
ciated with dementia, we computed odds ratios for the associations
between these diseases by meta-analyzing data from the four cohorts
and using the Mantel-Haenszel odds ratio method without continuity
correction.31
We used Stata MP 15 and 16 to analyze the data. The syntax for
these analyses is available in the Appendix (Methods A.3). We report
all confidence intervals at a 95% confidence level.
3 RESULTS
Table 1 provides the participants’ demographic characteristics (for
cohort-specific characteristics, see Table A.3 and for characteristics
split by the presence or absence of a physical disease, see Table A.4 in
the Appendix). During the 5,488,175 person-years at risk, we recorded
3416 incident cases of dementia. Of these, 1933 (56.6%) were
diagnosed as Alzheimer’s disease, 219 (6.4%) as vascular dementia,
5 (0.1%) as comorbid Alzheimer’s disease and vascular dementia, and
908 (26.6%) as other dementias. For 351 cases (10.3%), no informa-
tion on the type of dementiawas available.We identified 1501 incident
dementia cases from inpatient hospital discharge records, 814 from
other hospital records, 1076 from anti-dementia medication reim-
bursement entitlements, and25 fromdeath certificates.Of the demen-
tia cases, 667 were early onset and 2749 late-onset (Figure A.4 in the
Appendix).Dementia incidenceper100,000person-yearsbyagegroup
was 13 for participants younger than 65, 213 for individuals aged 65 to
69, 559 for those aged 70 to 74, 1280 for those aged 75 to 79, 2364 for
those aged 80 to 84, and 3760 for those aged 85 or older.
Figure 1 shows the hazard ratios of dementia associated with
the 22 physical diseases assessed. After Bonferroni correction,
17 of these diseases were associated with dementia in the full follow-
up (P < .0023), and for eight diseases, the association with demen-
tia remained robust when we considered only incident dementia
cases occurring from year 10 onward (Table A.5 in the Appendix
shows summary estimates by ICD-10 Chapter). These eight diseases
were erysipelas, hypothyroidism, acute myocardial infarction, chronic
ischemic heart disease, cerebral infarction, duodenal ulcer, gastritis
TABLE 1 Characteristics of participants at study entry
No. (%)
Demographic (N= 283,414)























Age at dementia diagnosis, median (range),
years
73.0 (22.7–93.2)
and duodenitis, and osteoporosis. The hazard ratios for these diseases
ranged between 1.3 and 2.4 and were thus comparable to or higher
than the relative risk estimates for conventional potentially modifi-
able dementia risk factors (Figure 2 [Table A.6 in the Appendix shows
detailed data]). Unlike for the other five diseases, the hazard of demen-
tia was not proportional for hypothyroidism, cerebral infarction, or
osteoporosis, as the hazard ratio for dementia declinedwith increasing
age (Figure A.2 in the Appendix).
As shown in Figure 3, cerebral infarction and osteoporosis were
more strongly associated with early and late-onset dementia (P for
difference < .05), whereas the strength of the association for the
remaining six physical diseases did not differ between early and late-
onset dementia. For comparison, the associations between conven-
tional risk factors and dementia did not differ between early and late-
onset dementia (Table A.7 in the Appendix).
Table 2 shows that the disease–dementia associations were gen-
erally slightly attenuated when vascular dementia was excluded from
dementia definition. The only exception was cerebral infarction, which
was associated with a 2.4-fold increased risk of dementia before but
only a 1.8-fold increased risk after exclusion. Fine-Gray models, with
mortality as the competing risk, revealed sub-hazard ratios that were
only slightly lower than the hazard ratios in the main analysis. Of the
eight diseases, cardiovascular diseases (acute myocardial infarction,












CONVENTIONAL RISK FACTORS PHYSICAL DISEASES
Our estimate Previous meta-analysis (low estimate) Previous meta-analysis (high estimate)
F IGURE 2 Hazard ratio for dementia for conventional risk factors versus physical diseases. The bars represent 95% confidence intervals.
Numerical estimates are reported in Table A.6 in the Appendix and their references are provided in the Appendix (p. 99). Our estimates for physical
diseases are the same as those from full dementia follow-up in Figure 1. The low and high estimates for the hazard ratios for conventional risk
factors are from 16meta-analyses.
Early-onset dementia (onset before age 65)
Late-onset dementia (onset at age 65 or older)
Participants with index disease Participants without index disease
Hazard ratio Hazard ratio      (Exposure group)          (Reference group) P for difference between
Disease (ICD-10 code) (95% confidence interval) (95% confidence interval) N (total) N (dementia cases) N (total) N (dementia cases) early and late-onset dementia
Erysipelas (A46) 1.96 (1.19-3.22) 3714 16 278616 651 .76
1.80 (1.50-2.17) 1959 119 70872 2630
Other hypothyroidism (E03) 3.47 (1.91-6.30) 1754 11 280576 656 .05
1.84 (1.48-2.28) 1475 88 71356 2661
Acute myocardial infarction (I21) 1.04 (0.46-2.32) 2363 6 279967 661 .45
1.43 (1.22-1.67) 2849 167 69982 2582
Chronic ischemic heart disease (I25) 1.54 (0.93-2.54) 3734 16 278596 651 .54
1.31 (1.16-1.48) 5323 314 67508 2435
Cerebral infarction (I63) 6.79 (4.72-9.77) 2278 31 280052 636 <.001
2.23 (1.95-2.55) 2849 234 69982 2515
Duodenal ulcer (K26) 2.04 (0.91-4.55) 868 6 281462 661 .084
1.86 (1.37-2.51) 605 43 72226 2706
Gastritis and duodenitis (K29) 2.43 (1.26-4.70) 1597 9 280733 658 .37
1.76 (1.39-2.23) 1318 75 71513 2674
Osteoporosis without pathological fracture (M81) 9.76 (3.64-26.13) 204 4 282126 663 .005
2.20 (1.60-3.03) 515 40 72316 2709
Favor lower risk Favor higher risk
Abbreviations: ICD-10, International Classification of Diseases, 10th Revision.
The bars represent 95% confidence intervals. Age is the time scale and hazard ratios are adjusted for sex.
The within-study clustering of participants was taken into account using cohort-specific baseline hazards and cohort-specific adjustment terms for sex.
0.25 0.5 1 2 4 8 1 6 32
F IGURE 3 Hazard ratio for early onset and late-onset dementia by exposure to eight physical diseases. ICD-10, International Classification of
Diseases, 10th Revision. The bars represent 95% confidence intervals. Age is the time scale and hazard ratios are adjusted for sex. Thewithin-study
clustering of participants has been taken into account using cohort-specific baseline hazards and cohort-specific adjustment terms for sex.
chronic ischemic heart disease, and cerebral infarction) were strongly
clustered with each other (odds ratios 5.2 to 58.4) and duodenal ulcer
was strongly associated with gastritis and duodenitis (odds ratio 12.7)
(Figure A.5 in the Appendix). Despite this clustering, the association of
eachof the eight diseaseswithdementia remainedafter adjustment for
the other diseases (Table 2).
The disease–dementia associations were only slightly attenuated
by adjustments for conventional dementia risk factors (low educa-
tion/socioeconomic status, hypertension, obesity, smoking, depression,
physical inactivity, marital status, and diabetes, and significant inter-
actions between them) (Table 3). In a subcohort with relevant data
available, adjustment for APOE genotype (no vs any ε4 allele) had little
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TABLE 2 Sensitivity analyses for the associations of eight physical diseases with subsequent dementia













Erysipelas (A46) 1.82 (1.53–2.17) 1.77 (1.48–2.13) 1.66 (1.40–1.98) 1.68 (1.41–2.00)
Other hypothyroidism (E03) 1.94 (1.59–2.38) 1.96 (1.53–2.52) 1.77 (1.44–2.17) 1.94 (1.66–2.28)
Acutemyocardial infarction (I21) 1.41 (1.20–1.64) 1.36 (1.14–1.62) 1.27 (1.09–1.49) 1.34 (1.25–1.43)
Chronic ischemic heart disease (I25) 1.32 (1.18–1.49) 1.20 (1.05–1.38) 1.20 (1.06–1.35) 1.32 (1.18–1.47)
Cerebral infarction (I63) 2.44 (2.14–2.77) 1.82 (1.56–2.12) 2.27 (1.99–2.58) 2.18 (1.80–2.64)
Duodenal ulcer (K26) 1.88 (1.42–2.49) 1.84 (1.34–2.53) 1.72 (1.29–2.29) 1.57 (1.41–1.76)
Gastritis and duodenitis (K29) 1.82 (1.46–2.27) 1.64 (1.18–2.27) 1.61 (1.28–2.01) 1.62 (1.36–1.93)
Osteoporosis without pathological
fracture (M81)
2.38 (1.75–3.23) 2.33 (1.52–3.60) 2.00 (1.47–2.71) 2.32 (1.85–2.90)
Abbreviations: CI, confidence interval; ICD-10, International Classification of Diseases, 10th Revision.
Analyses are based on 283,414 participants of whom 3416 developed incident dementia, except for the model excluding vascular dementia, which is based
on 273,381 participants of whom 2846 developed incident dementia.
Hazard ratios are adjusted for sex and age in the time scale.
The estimates frommain analysis are the same as those from full dementia follow-up in Figure 1.
aAdditionally adjusted for the seven other physical diseases with robust long-term association with dementia. (There were two diseases reflecting coronary
heart disease: myocardial infarction and chronic ischemic heart disease. To avoid over-adjustment, these two diseases were not adjusted for the other one.)
effect on hazard ratios (Table A.8 in the Appendix; note that numbers
were insufficient for erysipelas). Associations with dementia were also
replicated using only data on the primary reason for hospitalization to
define the eight physical diseases, considering only incident hospital-
izations from index diseases that occurred after study baseline, and
after excluding cases with missing information on the type of demen-
tia (Figure A.6-8 in the Appendix).
4 DISCUSSION
In this exploratory multicohort study of over 280,000 adults, we quan-
tified the associations of hospitalizations from 22 physical diseases
with a subsequent risk of dementia during a 19-year follow-up. For
eight diseases—including cardiovascular disease, inflammatory and
infectious diseases, and bone disorders—the hazard ratios for incident
dementia varied between 1.3 and 2.4 andwere thus comparable to the
relative risk estimates reported for conventional potentially modifi-
able dementia risk factors. The associations between the eight diseases
anddementiawereonly slightly attenuatedbyadjustments for conven-
tional dementia risk factors including low education/socioeconomic
status, hypertension, obesity, smoking, depression, physical inactivity,
marital status, and diabetes. The associations with incident dementia
also remainedwhenhospitalization for the disease occurredmore than
10 years before the diagnosis of dementia.
To our knowledge, no long-term follow-ups of the associations
between erysipelas, duodenal ulcer, gastritis, duodenitis, and dementia
have been reported previously. However, a nationwide Danish study
detected a higher risk of unspecified dementia or other degenerative
diseases of the nervous system for erysipelas (risk ratio 1.2), duo-
denal ulcer (1.1), and gastritis and duodenitis (1.4) during a shorter
5-year follow-up.22 Earlier evidence of the association between
hypothyroidism and dementia is also sparse.32–35
A comparison of our findings on dementia-related cardiovascular
disease to those of studies that have included clinical examinations
to ascertain dementia supports the validity of our approach. In the
full follow-up, our hazard ratios for acute myocardial infarction and
chronic ischemic heart disease were 1.4 and 1.3, similar to the relative
risk estimate of 1.3 for coronary heart disease and all-cause demen-
tia in a recentmeta-analysis.16 For cerebral infarction, our hazard ratio
was 2.4, whereas it was 2.2 in the 2018 systematic review and meta-
analysis.15 The present finding on osteoporosis is also consistent with
previous studies reporting an association between low bone mineral
density and dementia.36,37
Several proposed pathological mechanisms may explain the
associations between physical diseases and increased dementia
risk. According to genetic studies, the immune system may play
a role in the etiology of Alzheimer’s disease.20,21 Animal studies
suggest that systemic inflammation can increase the blood–brain
barrier’s permeability,38 induce inflammation into the central nervous
system,39 and cause long-term alterations in innate immune cells in
the brain and an increased deposition of amyloid plaques, the hallmark
of Alzheimer’s pathology.40 Sydenham’s chorea is a specific example
of a post-infectious autoimmune neurological disorder. It is a rare con-
sequence of group A Streptococcus pharyngitis but is of interest here
because erysipelas is also often caused by group A streptococci.41,42
Inflammation may also contribute to increased dementia risk among
thosewith duodenal ulcers, gastritis, and duodenitis.Helicobacter pylori
infection is a shared cause of these diseases.43,44 The evidence on the
association between H. pylori infection and dementia is mixed45; it is
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TABLE 3 Association of eight physical diseases with subsequent
dementia after adjustment for modifiable risk factors
Hazard ratio (95%CI)




Erysipelas (A46) 1.36 (0.78–2.36) 1.30 (0.74–2.26)
Other hypothyroidism (E03) 2.02 (1.42–2.87) 1.92 (1.35–2.73)
Acutemyocardial infarction
(I21)
1.44 (0.96–2.17) 1.32 (0.88–1.99)
Chronic ischemic heart disease
(I25)
1.62 (1.27–2.07) 1.47 (1.15–1.88)
Cerebral infarction (I63) 3.34 (2.39–4.68) 3.05 (2.17–4.28)
Duodenal ulcer (K26) 2.19 (1.21–3.98) 1.83 (1.00–3.35)
Gastritis and duodenitis (K29) 2.07 (1.51–2.83) 1.89 (1.38–2.60)
Osteoporosis without
pathological fracture (M81)
2.69 (1.75–4.15) 2.54 (1.64–3.94)
Abbreviations: CI, confidence interval; ICD-10, International Classification
of Diseases, 10th Revision.
All analyses are based on 121,696 participants without missing data on
modifiable risk factors. Of these, 859 developed incident dementia during
the follow-up.
The within-study clustering of participants was taken into account using
cohort-specific baseline hazards and cohort-specific adjustment terms for
covariates and interactions between them.
aModel A is adjusted for sex and age is the time scale.
bModel B is adjusted for sex and modifiable risk factors (low educa-
tion/socioeconomic status, hypertension, obesity, smoking, depression,
physical inactivity, marital status, and diabetes) and significant interactions
between the adjusting variables. Age is the time scale.
possible that only the severe (hospital-treated) forms of this infection
are linked to the development of dementia.
The mechanisms underlying the observed association between
osteoporosis and dementia are unclear. It has been suggested that low
cumulative exposure to estrogen (a female sex hormone) is a common
cause of osteoporosis and dementia,36 but findings on estrogen expo-
sure and dementia are conflicting,46,47 and osteoporosis has shown
similar associations with dementia among men as among women.37 A
further possibility, supported by the associations between osteoporo-
sis and other diseases, is that osteoporosis represents a general indica-
tor of poor health.
Plausible pathologicalmechanisms linking cardiovascular disease to
dementia involve neuronal damage caused by microinfarcts, microb-
leeds, white matter lesions, and brain atrophy.48 We found that
myocardial infarction and chronic ischemic heart disease were asso-
ciated with an increased risk of dementia, even after adjustment
for hypertension, which is an established vascular risk factor for
dementia.1,3,4 In addition to direct neuronal damage, the association
between cerebral infarction and dementia may reflect the impact of
underlying systemic vascular disease. Little is known about themecha-
nisms underlying the association between hypothyroidism and demen-
tia, although they could involve both direct effects on cognition and
indirect effects through vascular pathology.32,33,35
Our study has some important strengths. We investigated, in a sin-
gle analytic setting, 22 physical diseases that have been associated
previously with a higher incidence of dementia in the short-term (i.e.,
during the following 5 years), have been on a disease trajectory lead-
ing to dementia, or have been studied in separate studies with varying
settings.22 In contrast to earlier analyses, we also examined long-term
associations that were less likely to be attributable to reverse causa-
tion and ascertainment biases.
Our study also has limitations and therefore should be considered
hypothesis generating rather than conclusive. Although our main anal-
ysis of most diseases was well powered, the number of dementia cases
among those exposed to the index diseases was low in some sensitivity
analyses (e.g., occlusion and stenosis of precerebral arteries). For this
reason, we may have missed diseases that are associated with an
increased risk of dementia (Table A.9 in the Appendix). Given that the
reproducibility of the findings was not confirmed in an independent
study population, it also remains unclear whether our findings are
replicable. We retrieved the information on the index diagnoses and
incident dementia from electronic health records. This enabled all
participants recruited for the study to be included in the analyses,
rather than only those who continued to participate in follow-up
examinations. However, although electronic health records have
high positive predictive value (false positives are unlikely), they miss
mild and undiagnosed cases of diseases.49 This lack of sensitivity
could contribute to the dilution of the results by nondifferential
misclassification. The generalizability of our results is uncertain as the
participants were mostly from occupational cohorts and therefore
healthier than the general population. Our sample was relatively
young, meaning a higher than usual proportion of early onset dementia
cases. This may have led to an overestimation of the overall dementia
risk related to cerebral infarction and osteoporosis, as these diseases
had stronger associations with early than with late-onset dementia.
Due to reliance on observational data, our results may have been
affected by confounding due to imprecise or lacking measurements of
relevant covariates, such as conditions shared with the index disease
(e.g., frailty) or off-target effects of medications used to treat these
diseases.
5 CONCLUSION
In this exploratory study, the associations between eight physical
diseases (erysipelas, hypothyroidism, myocardial infarction, ischemic
heart disease, cerebral infarction, duodenal ulcer, gastritis and
duodenitis, and osteoporosis) and dementia were equally strong or
stronger than those between several currently targeted risk factors
(low education, hypertension, obesity, smoking, depression, physi-
cal inactivity, social isolation, and diabetes) and dementia. Further
research on the mechanisms underlying these disease–dementia
associations is needed to examine whether the observed associations
are causal and to confirm the relevance of our findings for dementia
etiology and prevention.
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